NCT07288073 2026-02-13TIL Therapy in cSCC and MCCDana-Farber Cancer InstitutePhase 2 Recruiting14 enrolled
NCT04562129 2026-01-29IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma PatientsH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting29 enrolled